KalVista Pharmaceuticals, Inc. (KALV) Share-based Payment Arrangement, Expense USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • KalVista Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending July 31, 2023 was $3.25 M, a 23.2% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.92 M, a 10.5% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.1 M, a 55.7% increase from 2020.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $7.12 M, a 60% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $3.25 M +$612 K +23.2% May 1, 2023 Jul 31, 2023 10-Q 2023-09-07
Q2 2022 $2.64 M -$153 K -5.47% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q2 2021 $2.8 M +$1.61 M +135% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q2 2020 $1.19 M +$114 K +10.6% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q2 2019 $1.07 M +$727 K +210% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q2 2018 $347 K +$126 K +57% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q2 2017 $221 K -$91 K -29.2% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q3 2016 $1.3 M $282 K -$7 K -2.42% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $1.31 M $312 K +$275 K +743% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-12
Q1 2016 $1.04 M $368 K +$250 K +212% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $785 K $341 K +$169 K +98.3% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 $616 K $289 K +$189 K +189% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $427 K $37 K -$13 K -26% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $440 K $118 K +$59 K +100% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $381 K $172 K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $100 K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $50 K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $59 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.